US Stock MarketDetailed Quotes

XBIT XBiotech

Watchlist
  • 2.980
  • +0.100+3.47%
Close May 15 16:00 ET
90.85MMarket Cap-2.31P/E (TTM)

XBiotech Key Stats

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

Quarterly+Annual
YOY yoy
Hide blank lines yoy
(FY)Dec 31, 2024
(Q4)Dec 31, 2024
(Q3)Sep 30, 2024
(Q2)Jun 30, 2024
(Q1)Mar 31, 2024
(FY)Dec 31, 2023
(Q4)Dec 31, 2023
(Q3)Sep 30, 2023
(Q2)Jun 30, 2023
(Q1)Mar 31, 2023
Assets
Current assets
Cash, cash equivalents and short term investments
-13.67%172.68M
-13.67%172.68M
-9.43%183.12M
-7.93%188.53M
-5.47%201.04M
-8.03%200.02M
-8.03%200.02M
-8.14%202.19M
-9.31%204.77M
-8.26%212.66M
-Cash and cash equivalents
-13.67%172.68M
-13.67%172.68M
-9.43%183.12M
31.48%188.53M
31.84%201.04M
27.16%200.02M
27.16%200.02M
25.92%202.19M
-36.49%143.39M
-34.22%152.48M
-Short-term investments
----
----
----
----
----
----
----
--0
--61.38M
--60.18M
Receivables
-8.24%858K
-8.24%858K
-34.61%871K
-73.83%993K
-67.63%945K
-47.00%935K
-47.00%935K
-50.78%1.33M
-69.47%3.79M
-72.27%2.92M
-Accounts receivable
----
----
----
----
----
----
----
-42.42%881K
--3.22M
374.20%2.37M
-Accrued interest receivable
-18.60%700K
-18.60%700K
--730K
--870K
--870K
-29.28%860K
-29.28%860K
----
----
----
-Taxes receivable
110.67%158K
110.67%158K
-68.74%141K
-78.68%123K
-86.31%75K
-86.31%75K
-86.31%75K
-61.65%451K
-95.36%577K
-94.53%548K
Other current assets
35.79%1.03M
35.79%1.03M
18.89%1.05M
17.85%1.12M
52.49%1.07M
26.46%760K
26.46%760K
--879K
--947K
--703K
Total current assets
-13.46%174.57M
-13.46%174.57M
-9.48%185.03M
-9.01%190.64M
-6.12%203.06M
-8.24%201.72M
-8.24%201.72M
-8.52%204.4M
-12.25%209.51M
-10.99%216.28M
Non current assets
Net PPE
-1.49%24.53M
-1.49%24.53M
-1.51%24.82M
-2.76%24.92M
-4.00%24.8M
-5.19%24.9M
-5.19%24.9M
-5.40%25.2M
-6.06%25.62M
-7.14%25.84M
-Gross PPE
3.19%44.51M
3.19%44.51M
-1.51%24.82M
-2.76%24.92M
-4.00%24.8M
0.89%43.14M
0.89%43.14M
-5.40%25.2M
-6.06%25.62M
-7.14%25.84M
-Accumulated depreciation
-9.57%-19.99M
-9.57%-19.99M
----
----
----
-10.57%-18.24M
-10.57%-18.24M
----
----
----
Total non current assets
-1.49%24.53M
-1.49%24.53M
-1.51%24.82M
-2.76%24.92M
-4.00%24.8M
-5.19%24.9M
-5.19%24.9M
-8.06%25.2M
-7.49%25.62M
-7.14%25.84M
Total assets
-12.14%199.09M
-12.14%199.09M
-8.60%209.85M
-8.33%215.56M
-5.89%227.86M
-7.92%226.62M
-7.92%226.62M
-8.47%229.6M
-11.76%235.14M
-10.59%242.12M
Liabilities
Current liabilities
Payables
-14.47%2.22M
-14.47%2.22M
-7.44%1.51M
-1.60%1.79M
90.51%2.69M
5.52%2.6M
5.52%2.6M
2.33%1.63M
-31.39%1.82M
6.73%1.41M
-accounts payable
-11.65%2.22M
-11.65%2.22M
2.59%1.51M
-6.17%1.7M
92.11%2.61M
4.49%2.52M
4.49%2.52M
6.69%1.47M
-26.00%1.82M
2.57%1.36M
-Total tax payable
--0
--0
--0
--83K
50.91%83K
50.91%83K
50.91%83K
-25.70%159K
--0
--55K
Current accrued expenses
-31.24%2.02M
-31.24%2.02M
22.33%4.49M
103.04%5.35M
90.12%4.19M
163.82%2.94M
163.82%2.94M
84.46%3.67M
-52.86%2.63M
40.69%2.21M
Current debt and capital lease obligation
--10.25M
--10.25M
--10M
--10M
--10M
----
----
----
----
----
-Current debt
--10.25M
--10.25M
--10M
--10M
--10M
----
----
----
----
----
Current liabilities
147.62%15.11M
147.62%15.11M
202.08%15.99M
285.06%17.14M
366.67%16.88M
50.02%6.1M
50.02%6.1M
47.96%5.29M
-45.96%4.45M
25.15%3.62M
Non current liabilities
Non current deferred liabilities
----
----
----
----
----
----
----
--0
--0
--0
Total non current liabilities
3.06%1.72M
3.06%1.72M
5.95%1.74M
5.91%1.72M
6.01%1.69M
2.08%1.67M
2.08%1.67M
-32.73%1.65M
-33.26%1.62M
-32.06%1.6M
Total liabilities
116.57%16.83M
116.57%16.83M
155.56%17.74M
210.46%18.85M
256.17%18.58M
36.27%7.77M
36.27%7.77M
15.19%6.94M
-43.07%6.07M
-0.51%5.22M
Shareholders'equity
Share capital
0.72%273.11M
0.72%273.11M
0.95%272.44M
1.15%272.02M
1.33%271.59M
1.43%271.15M
1.43%271.15M
1.35%269.89M
1.42%268.93M
1.64%268.03M
-common stock
0.72%273.11M
0.72%273.11M
0.95%272.44M
1.15%272.02M
1.33%271.59M
1.43%271.15M
1.43%271.15M
1.35%269.89M
1.42%268.93M
1.64%268.03M
-Preferred stock
--0
--0
--0
--0
--0
--0
--0
--0
--0
--0
Retained earnings
-73.66%-90.84M
-73.66%-90.84M
-68.51%-80.33M
-86.85%-75.31M
-97.40%-62.31M
-88.50%-52.31M
-88.50%-52.31M
-94.21%-47.67M
-239.06%-40.31M
-12,836.48%-31.57M
Gains losses not affecting retained earnings
----
----
----
----
----
----
----
-85.66%440K
-82.57%440K
-78.98%440K
Total stockholders'equity
-16.71%182.27M
-16.71%182.27M
-13.72%192.12M
-14.13%196.7M
-11.66%209.28M
-8.97%218.85M
-8.97%218.85M
-9.05%222.66M
-10.45%229.06M
-10.79%236.91M
Total equity
-16.71%182.27M
-16.71%182.27M
-13.72%192.12M
-14.13%196.7M
-11.66%209.28M
-8.97%218.85M
-8.97%218.85M
-9.05%222.66M
-10.45%229.06M
-10.79%236.91M
Currency Unit
USD
USD
USD
USD
USD
USD
USD
USD
USD
USD
Audit Opinions
Unqualified Opinion
--
--
--
--
Unqualified Opinion
--
--
--
--
(FY)Dec 31, 2024(Q4)Dec 31, 2024(Q3)Sep 30, 2024(Q2)Jun 30, 2024(Q1)Mar 31, 2024(FY)Dec 31, 2023(Q4)Dec 31, 2023(Q3)Sep 30, 2023(Q2)Jun 30, 2023(Q1)Mar 31, 2023
Assets
Current assets
Cash, cash equivalents and short term investments -13.67%172.68M-13.67%172.68M-9.43%183.12M-7.93%188.53M-5.47%201.04M-8.03%200.02M-8.03%200.02M-8.14%202.19M-9.31%204.77M-8.26%212.66M
-Cash and cash equivalents -13.67%172.68M-13.67%172.68M-9.43%183.12M31.48%188.53M31.84%201.04M27.16%200.02M27.16%200.02M25.92%202.19M-36.49%143.39M-34.22%152.48M
-Short-term investments ------------------------------0--61.38M--60.18M
Receivables -8.24%858K-8.24%858K-34.61%871K-73.83%993K-67.63%945K-47.00%935K-47.00%935K-50.78%1.33M-69.47%3.79M-72.27%2.92M
-Accounts receivable -----------------------------42.42%881K--3.22M374.20%2.37M
-Accrued interest receivable -18.60%700K-18.60%700K--730K--870K--870K-29.28%860K-29.28%860K------------
-Taxes receivable 110.67%158K110.67%158K-68.74%141K-78.68%123K-86.31%75K-86.31%75K-86.31%75K-61.65%451K-95.36%577K-94.53%548K
Other current assets 35.79%1.03M35.79%1.03M18.89%1.05M17.85%1.12M52.49%1.07M26.46%760K26.46%760K--879K--947K--703K
Total current assets -13.46%174.57M-13.46%174.57M-9.48%185.03M-9.01%190.64M-6.12%203.06M-8.24%201.72M-8.24%201.72M-8.52%204.4M-12.25%209.51M-10.99%216.28M
Non current assets
Net PPE -1.49%24.53M-1.49%24.53M-1.51%24.82M-2.76%24.92M-4.00%24.8M-5.19%24.9M-5.19%24.9M-5.40%25.2M-6.06%25.62M-7.14%25.84M
-Gross PPE 3.19%44.51M3.19%44.51M-1.51%24.82M-2.76%24.92M-4.00%24.8M0.89%43.14M0.89%43.14M-5.40%25.2M-6.06%25.62M-7.14%25.84M
-Accumulated depreciation -9.57%-19.99M-9.57%-19.99M-------------10.57%-18.24M-10.57%-18.24M------------
Total non current assets -1.49%24.53M-1.49%24.53M-1.51%24.82M-2.76%24.92M-4.00%24.8M-5.19%24.9M-5.19%24.9M-8.06%25.2M-7.49%25.62M-7.14%25.84M
Total assets -12.14%199.09M-12.14%199.09M-8.60%209.85M-8.33%215.56M-5.89%227.86M-7.92%226.62M-7.92%226.62M-8.47%229.6M-11.76%235.14M-10.59%242.12M
Liabilities
Current liabilities
Payables -14.47%2.22M-14.47%2.22M-7.44%1.51M-1.60%1.79M90.51%2.69M5.52%2.6M5.52%2.6M2.33%1.63M-31.39%1.82M6.73%1.41M
-accounts payable -11.65%2.22M-11.65%2.22M2.59%1.51M-6.17%1.7M92.11%2.61M4.49%2.52M4.49%2.52M6.69%1.47M-26.00%1.82M2.57%1.36M
-Total tax payable --0--0--0--83K50.91%83K50.91%83K50.91%83K-25.70%159K--0--55K
Current accrued expenses -31.24%2.02M-31.24%2.02M22.33%4.49M103.04%5.35M90.12%4.19M163.82%2.94M163.82%2.94M84.46%3.67M-52.86%2.63M40.69%2.21M
Current debt and capital lease obligation --10.25M--10.25M--10M--10M--10M--------------------
-Current debt --10.25M--10.25M--10M--10M--10M--------------------
Current liabilities 147.62%15.11M147.62%15.11M202.08%15.99M285.06%17.14M366.67%16.88M50.02%6.1M50.02%6.1M47.96%5.29M-45.96%4.45M25.15%3.62M
Non current liabilities
Non current deferred liabilities ------------------------------0--0--0
Total non current liabilities 3.06%1.72M3.06%1.72M5.95%1.74M5.91%1.72M6.01%1.69M2.08%1.67M2.08%1.67M-32.73%1.65M-33.26%1.62M-32.06%1.6M
Total liabilities 116.57%16.83M116.57%16.83M155.56%17.74M210.46%18.85M256.17%18.58M36.27%7.77M36.27%7.77M15.19%6.94M-43.07%6.07M-0.51%5.22M
Shareholders'equity
Share capital 0.72%273.11M0.72%273.11M0.95%272.44M1.15%272.02M1.33%271.59M1.43%271.15M1.43%271.15M1.35%269.89M1.42%268.93M1.64%268.03M
-common stock 0.72%273.11M0.72%273.11M0.95%272.44M1.15%272.02M1.33%271.59M1.43%271.15M1.43%271.15M1.35%269.89M1.42%268.93M1.64%268.03M
-Preferred stock --0--0--0--0--0--0--0--0--0--0
Retained earnings -73.66%-90.84M-73.66%-90.84M-68.51%-80.33M-86.85%-75.31M-97.40%-62.31M-88.50%-52.31M-88.50%-52.31M-94.21%-47.67M-239.06%-40.31M-12,836.48%-31.57M
Gains losses not affecting retained earnings -----------------------------85.66%440K-82.57%440K-78.98%440K
Total stockholders'equity -16.71%182.27M-16.71%182.27M-13.72%192.12M-14.13%196.7M-11.66%209.28M-8.97%218.85M-8.97%218.85M-9.05%222.66M-10.45%229.06M-10.79%236.91M
Total equity -16.71%182.27M-16.71%182.27M-13.72%192.12M-14.13%196.7M-11.66%209.28M-8.97%218.85M-8.97%218.85M-9.05%222.66M-10.45%229.06M-10.79%236.91M
Currency Unit USDUSDUSDUSDUSDUSDUSDUSDUSDUSD
Audit Opinions Unqualified Opinion--------Unqualified Opinion--------

Market Insights

Best Growth Stocks Best Growth Stocks

Spot stocks with huge growth potential and solid financial standing. Spot stocks with huge growth potential and solid financial standing.

No. Symbol Price
YETI Holdings
YETI
32.160
Halozyme Therapeutics
HALO
48.950
eBay
EBAY
70.600
4
Constellation Brands
STZ
190.650
5
Workday
WDAY
274.710
Log In for the Full List
Unlock Now

Investment Course

Top 5 Industries for Stock Trading under Trump's Second Term
Stocks & Industries to Watch Under Trump's Second Presidency
With mooomoo, find out which stocks and industries may benefit from Trump's second presidency, based on his first administration's track record.

Reassessing Chinese Assets

Following the introduction of China's groundbreaking DeepSeek technology, Wall Street giants have revised their investment outlooks for the Chinese market.

Discussing

Trade war escalates: What’s next for Chinese stocks?
🎙️Discussion 1. China-EU EV negotiations kick off recently. How do you think the negotiations will impact the performance of related stocks Show More
Alibaba Q4 FY2024 Earnings Preview: Predict & Win Big! 🚀